NCT03954067 A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03941262 Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy Status COMPLETED Phase PHASE1
NCT03936959 A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer Status TERMINATED Phase PHASE1
NCT03922204 A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies Status COMPLETED Phase PHASE1
NCT03909334 Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03900442 Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort Status COMPLETED Phase PHASE1
NCT03875781 Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer Status RECRUITING Phase PHASE3
NCT03860272 Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03851146 A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours Status COMPLETED Phase PHASE1
NCT03837132 Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer Status COMPLETED Phase N/A
NCT03833817 Patient-caregiver Communication Intervention for Prognostic Understanding Status COMPLETED Phase NA
NCT03833479 TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03829501 A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03829254 A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT03823313 Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention Status COMPLETED Phase NA
NCT03811379 Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy Status UNKNOWN Phase PHASE2
NCT03810339 Toripalimab(JS001) as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors Status RECRUITING Phase PHASE2